In the Journals

This feature offers timely executive summaries of the most relevant journals in rheumatology. Through peer “Perspectives,” full bibliographical information and links to the original journal abstract, In the Journals are a step wider and deeper than journal reviews health care professionals may be accustomed.

In the JournalsPerspective

Prior authorization linked to treatment delays

October 7, 2019
Prior authorization requirements are associated with delays in treatment, with denials linked to greater glucocorticoid exposure for patients…
In the JournalsPerspective

Continuous NSAID use for AS linked to increased hypertension risk

October 3, 2019
Continuous use of NSAIDs for the treatment of ankylosing spondylitis is associated with a 12% increased risk for incident hypertension, compared to…
In the Journals

BMI, diet, alcohol use significantly drive hyperuricemia cases

October 1, 2019
Maintaining a healthy BMI, adherence to the Dietary Approaches to Stop Hypertension, or DASH, diet, and reductions in alcohol and diuretic use may…
In the JournalsPerspective

Young adults with chronic diseases report more daily marijuana use

September 30, 2019
Patients with medical conditions are more likely to use marijuana than those without, with 11.2% of young adults living with chronic disease using it…
In the Journals

Rheumatologists value patient-reported RA symptoms over test results

September 26, 2019
When it comes to informing treatment decisions, rheumatologists value patient-reported symptoms and physical function over physical findings and test…
In the Journals

Disease burden, prescription use high in patients with both knee, hip OA

September 24, 2019
Disease burden is high, and prescriptions for analgesics are frequent, among patients with both knee and hip osteoarthritis, according to findings…
In the JournalsPerspective

Tocilizumab increases HDL, LDL cholesterol, triglycerides compared with etanercept in RA

September 23, 2019
Patients with rheumatoid arthritis who received tocilizumab demonstrated 11.1% higher serum LDL cholesterol, 5.7% higher HDL cholesterol and 13.6%…
In the Journals

Patient-reported outcome measures with Skindex may yield more comprehensive data

September 19, 2019
Relying primarily on patient global assessments falls short in determining comprehensive disease severity, but by adding the Skindex instrument or…
In the Journals

Adalimumab, IBI303 biosimilar demonstrate comparable safety, efficacy in AS

September 19, 2019
IBI303, a biosimilar to adalimumab developed by Chinese biopharmaceutical company Innovent Biologics, is comparable in safety and efficacy to the…
In the Journals

Infusion reactions to rituximab more significant in SLE than other diseases

September 17, 2019
Infusion reaction rates to rituximab may be more significant among patients with systemic lupus erythematosus than other diseases, according to…